BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28433699)

  • 1. EGFR-mediated apoptosis via STAT3.
    Jackson NM; Ceresa BP
    Exp Cell Res; 2017 Jul; 356(1):93-103. PubMed ID: 28433699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Picrasidine G decreases viability of MDA-MB 468 EGFR-overexpressing triple-negative breast cancer cells through inhibition of EGFR/STAT3 signaling pathway.
    Yamashita N; Kondo M; Zhao S; Li W; Koike K; Nemoto K; Kanno Y
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2608-2612. PubMed ID: 28427809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Icariside II induces apoptosis via inhibition of the EGFR pathways in A431 human epidermoid carcinoma cells.
    Wu J; Zuo F; Du J; Wong PF; Qin H; Xu J
    Mol Med Rep; 2013 Aug; 8(2):597-602. PubMed ID: 23807305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymoquinone induces apoptosis in human colon cancer HCT116 cells through inactivation of STAT3 by blocking JAK2- and Src‑mediated phosphorylation of EGF receptor tyrosine kinase.
    Kundu J; Choi BY; Jeong CH; Kundu JK; Chun KS
    Oncol Rep; 2014 Aug; 32(2):821-8. PubMed ID: 24890449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor-induced cell death and radiosensitization in epidermal growth factor receptor-overexpressing cancer cell lines.
    Kim K; Wu HG; Jeon SR
    Anticancer Res; 2015 Jan; 35(1):245-53. PubMed ID: 25550557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGF-induced apoptosis in A431 cells is dependent on STAT1, but not on STAT3.
    Grudinkin PS; Zenin VV; Kropotov AV; Dorosh VN; Nikolsky NN
    Eur J Cell Biol; 2007 Oct; 86(10):591-603. PubMed ID: 17646016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT3 and ERK Signaling Pathways Are Implicated in the Invasion Activity by Oncostatin M through Induction of Matrix Metalloproteinases 2 and 9.
    Ko HS; Park BJ; Choi SK; Kang HK; Kim A; Kim HS; Park IY; Shin JC
    Yonsei Med J; 2016 May; 57(3):761-8. PubMed ID: 26996579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MUC20 overexpression predicts poor prognosis and enhances EGF-induced malignant phenotypes via activation of the EGFR-STAT3 pathway in endometrial cancer.
    Chen CH; Wang SW; Chen CW; Huang MR; Hung JS; Huang HC; Lin HH; Chen RJ; Shyu MK; Huang MC
    Gynecol Oncol; 2013 Mar; 128(3):560-7. PubMed ID: 23262208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prostaglandin E2 receptor, EP2, regulates survivin expression via an EGFR/STAT3 pathway in UVB-exposed mouse skin.
    Chun KS; Langenbach R
    Mol Carcinog; 2011 Jun; 50(6):439-48. PubMed ID: 21268125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous silencing of β-catenin and signal transducer and activator of transcription 3 synergistically induces apoptosis and inhibits cell proliferation in HepG2 liver cancer cells.
    Wang XH; Liu MN; Huang P; Xu J; Liu AY; Chen J; Lv CQ; Xu RL
    Mol Med Rep; 2015 Aug; 12(2):2263-8. PubMed ID: 25845340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the AKT and STAT3 pathways and prolonged survival by a mutant EGFR in human lung cancer cells.
    Akca H; Tani M; Hishida T; Matsumoto S; Yokota J
    Lung Cancer; 2006 Oct; 54(1):25-33. PubMed ID: 16872715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The radio-sensitizing effect of xanthohumol is mediated by STAT3 and EGFR suppression in doxorubicin-resistant MCF-7 human breast cancer cells.
    Kang Y; Park MA; Heo SW; Park SY; Kang KW; Park PH; Kim JA
    Biochim Biophys Acta; 2013 Mar; 1830(3):2638-48. PubMed ID: 23246576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-associated macrophages regulate murine breast cancer stem cells through a novel paracrine EGFR/Stat3/Sox-2 signaling pathway.
    Yang J; Liao D; Chen C; Liu Y; Chuang TH; Xiang R; Markowitz D; Reisfeld RA; Luo Y
    Stem Cells; 2013 Feb; 31(2):248-58. PubMed ID: 23169551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer.
    Haura EB; Zheng Z; Song L; Cantor A; Bepler G
    Clin Cancer Res; 2005 Dec; 11(23):8288-94. PubMed ID: 16322287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tyrosine phosphorylated pro-survival form of Fas intensifies the EGF-induced signal in colorectal cancer cells through the nuclear EGFR/STAT3-mediated pathway.
    Ta NL; Chakrabandhu K; Huault S; Hueber AO
    Sci Rep; 2018 Aug; 8(1):12424. PubMed ID: 30127519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR induces expression of IRF-1 via STAT1 and STAT3 activation leading to growth arrest of human cancer cells.
    Andersen P; Pedersen MW; Woetmann A; Villingshøj M; Stockhausen MT; Odum N; Poulsen HS
    Int J Cancer; 2008 Jan; 122(2):342-9. PubMed ID: 17918184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interaction of specific peptide aptamers with the DNA binding domain and the dimerization domain of the transcription factor Stat3 inhibits transactivation and induces apoptosis in tumor cells.
    Nagel-Wolfrum K; Buerger C; Wittig I; Butz K; Hoppe-Seyler F; Groner B
    Mol Cancer Res; 2004 Mar; 2(3):170-82. PubMed ID: 15037656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor.
    Alvarez JV; Greulich H; Sellers WR; Meyerson M; Frank DA
    Cancer Res; 2006 Mar; 66(6):3162-8. PubMed ID: 16540667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR through STAT3 modulates ΔN63α expression to sustain tumor-initiating cell proliferation in squamous cell carcinomas.
    Ripamonti F; Albano L; Rossini A; Borrelli S; Fabris S; Mantovani R; Neri A; Balsari A; Magnifico A; Tagliabue E
    J Cell Physiol; 2013 Apr; 228(4):871-8. PubMed ID: 23018838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung Tumor Suppressor GPRC5A Binds EGFR and Restrains Its Effector Signaling.
    Zhong S; Yin H; Liao Y; Yao F; Li Q; Zhang J; Jiao H; Zhao Y; Xu D; Liu S; Song H; Gao Y; Liu J; Ma L; Pang Z; Yang R; Ding C; Sun B; Lin X; Ye X; Guo W; Han B; Zhou BP; Chin YE; Deng J
    Cancer Res; 2015 May; 75(9):1801-14. PubMed ID: 25744720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.